
ARIX BIOSCIENCE PLC
ARIX | IL
Overview
Corporate Details
- ISIN(s):
- GB00BD045071
- LEI:
- 213800OVT3AHQCXNIX43
- Country:
- United Kingdom
- Address:
- 1 More London Place, SE1 2AF London
- Website:
- http://arixbioscience.com/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
ARIX BIOSCIENCE PLC invests in innovative life sciences companies, supporting breakthroughs in biotechnology and healthcare.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for ARIX BIOSCIENCE PLC.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
Date | Filing | Language | Size | Actions |
---|---|---|---|---|
2024-02-12 14:02 |
Delisting Announcement
Arix Bioscience Plc - Results of 2nd General Meeting
|
English | 123.9 KB | |
2024-02-12 13:00 |
Post-Annual General Meeting Information
Scheme Effective
|
English | 28.0 KB | |
2024-02-12 08:00 |
Delisting Announcement
Suspension of Trading in Shares
|
English | 19.2 KB | |
2024-02-07 12:30 |
M&A Activity
Transaction Update
|
English | 30.8 KB | |
2024-01-29 14:06 |
Delisting Announcement
Arix Bioscience Plc - Results of 1st General Meeting
|
English | 61.5 KB | |
2024-01-29 13:15 |
Post-Annual General Meeting Information
Results of First General Meeting
|
English | 28.6 KB | |
2024-01-24 18:30 |
Major Shareholding Notification
Holding(s) in Company
|
English | 66.9 KB | |
2024-01-23 11:42 |
Pre-Annual General Meeting Information
Arix Bioscience Plc - Circular and Notice of Second General Meeting
|
English | 138.5 KB | |
2024-01-23 08:00 |
Pre-Annual General Meeting Information
Update on the Scheme and Publication of Notice of Second General Meeting
|
English | 39.2 KB | |
2024-01-22 08:00 |
M&A Activity
Update on the Scheme and Resignation of Directors
|
English | 22.4 KB | |
2024-01-19 08:01 |
Earnings Release
Financial update on Harpoon Therapeutics acquisition by Merck (MSD)
|
English | 11.7 KB | |
2024-01-19 08:00 |
Net Asset Value
Unaudited NAV for December 2023
|
English | 15.1 KB | |
2024-01-08 18:15 |
M&A Activity
Portfolio company Harpoon Therapeutics to be acquired by Merck (MSD)
|
English | 58.4 KB | |
2024-01-05 08:00 |
Proxy Solicitation & Information Statement
Publication of Circular and RTW Bio Prospectus
|
English | 43.5 KB | |
2024-01-04 18:30 |
Major Shareholding Notification
Holding(s) in Company
|
English | 66.4 KB |
Automate Your Workflow. Get a real-time feed of all ARIX BIOSCIENCE PLC filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for ARIX BIOSCIENCE PLC via our API.
Insider Transactions
Date | Insider Name | Position | Type | Shares | Value |
---|---|---|---|---|---|
No insider transactions recorded for this company. |